Litcius/Paper detail

Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program

Pamela A. Christopherson, Sandra L. Haberichter, Veronica H. Flood, Crystal L. Perry, Brooke Sadler, Daniel B. Bellissimo, Jorge Di Paola, Robert R. Montgomery, Thomas C. Abshire, Hartmut Weiler, David Lillicrap, Paula James, James S. O’Donnell, Christopher J. Ng, Carolyn M. Bennett, Robert F. Sidonio, M. Manco‐Johnson, Janna M. Journeycake, Ayesha Zia, Jeanne M. Lusher, Madhvi Rajpurkar, Amy D. Shapiro, Steven R. Lentz, M. John Gill, Cindy Leissinger, Margaret V. Ragni, Michael D. Tarantino, Jonathan Roberts, Jeffrey D. Hord, John J. Strouse, Alice Ma, Leonard A. Valentino, Lisa Boggio, Anjali Sharathkumar, Ralph A. Gruppo, Bryce A. Kerlin, R. KULKARNI, D Green, Keith Hoots, Deborah Brown, Donald H. Mahoney, Liesl Mathias, Adees Wirtan Sarkees Bedros, Carol Diamond, Anne T. Neff, Donna DiMichele, Patricia J. Giardina, Alan Cohen, Michael J. Paidas, Eric Werner, Atsuko Matsunaga, Frank Shafer, Barbara A. Konkle, Adam Cuker, Peter A. Kouides, Dagmar Stein

2022Journal of Thrombosis and Haemostasis21 citationsDOIOpen Access PDF

Topics & Concepts

Von Willebrand diseaseGeneticsVon Willebrand factorMissense mutationAllelic heterogeneityFrameshift mutationGenotypeAlleleBiologyGenetic heterogeneityGenetic testingPhenotypeMedicineImmunologyGenePlateletPlatelet Disorders and TreatmentsBlood disorders and treatmentsHeparin-Induced Thrombocytopenia and Thrombosis